What DBP and PP Signify
Diastolic blood pressure (DBP) represents the minimum arterial pressure during cardiac diastole and is the primary determinant of coronary perfusion pressure, while pulse pressure (PP)—calculated as systolic minus diastolic pressure—serves as the best surrogate marker for large artery stiffness and arterial compliance.
Diastolic Blood Pressure (DBP)
DBP reflects the arterial pressure during the heart's resting phase and is measured at the complete disappearance of Korotkoff sounds (fifth sound) using auscultatory technique, or estimated from mean arterial pressure by oscillometric devices 1.
Clinical Significance of DBP:
- Coronary perfusion determinant: Since myocardial perfusion occurs almost exclusively during diastole, DBP directly represents coronary perfusion pressure 2
- Age-dependent prognostic value: DBP is a stronger predictor of cardiovascular risk in younger adults (under 50-60 years), while its predictive power diminishes with age 3, 4
- Resistance marker: In middle-aged individuals, DBP primarily reflects peripheral vascular resistance 4
The J-Curve Phenomenon:
Excessively low DBP (particularly <60 mm Hg) poses cardiovascular risks, especially in patients with treated systolic hypertension. In patients achieving systolic BP <130 mm Hg, DBP <60 mm Hg was associated with significantly increased risk of cardiovascular events (HR 1.46), myocardial infarction (HR 1.73), and stroke (HR 2.67) 5. The optimal DBP range appears to be 70-80 mm Hg for patients with controlled systolic pressure 5.
This occurs because coronary autoregulation maintains blood flow down to approximately 40 mm Hg mean coronary filling pressure (roughly 30 mm Hg DBP), but below this threshold, myocardial perfusion becomes compromised 2. The risk is amplified in patients with left ventricular hypertrophy, coronary artery disease, or reduced coronary flow reserve.
Pulse Pressure (PP)
PP is calculated as systolic BP minus diastolic BP and represents the pulsatile component of blood pressure 1.
Clinical Significance of PP:
- Arterial stiffness marker: PP is the single best blood pressure surrogate for large artery stiffness and reduced vascular compliance 4, 6
- Age-related predictor: PP becomes the more powerful cardiovascular risk marker in middle-aged and elderly subjects (typically >55-60 years), surpassing both systolic and diastolic pressure as individual predictors 3, 4
- Risk stratification: Wide PP (≥55-60 mm Hg) identifies patients at particularly high cardiovascular risk, even among those with isolated systolic hypertension 3, 7
Pathophysiological Context:
Widened PP reflects arterial stiffening from atherosclerosis and aging, which causes systolic pressure to increase while diastolic pressure decreases 6, 8. This creates a paradoxical situation where normal DBP may mask underlying pathology—the combination of increased peripheral resistance (elevating DBP) and arterial stiffening (lowering DBP) can "cancel out," producing deceptively normal DBP readings despite significant cardiovascular risk 6.
Age-Specific Patterns:
- Younger adults (<50-60 years): Both systolic and diastolic pressures predict risk equally well; PP adds limited information 9
- Older adults (≥60 years): PP and systolic pressure become dominant predictors, while DBP loses predictive value and may even show inverse associations with outcomes 3, 4, 9
Clinical Application:
For hypertension classification and treatment decisions, systolic and diastolic pressures remain the primary measurements 10, 11, 12. However, understanding PP provides critical context:
- In isolated systolic hypertension with wide PP, cardiovascular risk is higher than in combined systolic/diastolic hypertension at similar systolic levels 4
- Ambulatory PP >53 mm Hg identifies markedly increased cardiovascular risk 13
- PP modifies the prognostic significance of DBP, particularly in patients with high PP (≥60 mm Hg), where both very low (≤60 mm Hg) and very high (≥101 mm Hg) DBP values predict worse kidney outcomes 14
The key clinical caveat: While PP provides valuable prognostic information, current treatment guidelines focus on systolic and diastolic targets because these have the most robust evidence from clinical trials demonstrating benefit from blood pressure reduction 10, 11, 12. PP should inform risk assessment but not replace standard BP measurements for treatment decisions.